Back to Search
Start Over
Myositis due to Sorafenib intake in a patient with hepatocellular carcinoma.
- Source :
-
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2011 Apr; Vol. 43 (4), pp. 333-4. Date of Electronic Publication: 2011 Jan 06. - Publication Year :
- 2011
- Subjects :
- Antineoplastic Agents therapeutic use
Benzenesulfonates therapeutic use
Humans
Male
Middle Aged
Myositis pathology
Niacinamide analogs & derivatives
Phenylurea Compounds
Pyridines therapeutic use
Sorafenib
Antineoplastic Agents adverse effects
Benzenesulfonates adverse effects
Carcinoma, Hepatocellular drug therapy
Liver Neoplasms drug therapy
Myositis chemically induced
Pyridines adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1878-3562
- Volume :
- 43
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
- Publication Type :
- Report
- Accession number :
- 21215716
- Full Text :
- https://doi.org/10.1016/j.dld.2010.11.009